Long-term efficacy and safety of once-daily fosamprenavir 1400 mg boosted by ritonavir 100 mg: the BOLD100 study.
about
Long-term efficacy and safety of once-daily fosamprenavir 1400 mg boosted by ritonavir 100 mg: the BOLD100 study.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Long-term efficacy and safety ...... vir 100 mg: the BOLD100 study.
@en
Long-term efficacy and safety ...... vir 100 mg: the BOLD100 study.
@nl
type
label
Long-term efficacy and safety ...... vir 100 mg: the BOLD100 study.
@en
Long-term efficacy and safety ...... vir 100 mg: the BOLD100 study.
@nl
prefLabel
Long-term efficacy and safety ...... vir 100 mg: the BOLD100 study.
@en
Long-term efficacy and safety ...... vir 100 mg: the BOLD100 study.
@nl
P2093
P2860
P356
P1476
Long-term efficacy and safety ...... vir 100 mg: the BOLD100 study.
@en
P2093
Boosting Once-daily Lexiva Delivery with ritonavir 100 mg QD [BOLD100] Study Team
P Greiger-Zanlungo
P2860
P304
P356
10.1258/IJSA.2009.009161
P577
2012-03-01T00:00:00Z